Meta-analysis of 14 studies demonstrates a significantly reduced risk of esophageal adenocarcinoma in patients with obesity undergoing metabolic and bariatric surgery, with an overall incidence reduction (OR=0.69) and particularly lower risk in European populations (OR: 0.60) and studies with larger sample sizes (OR: 0.59). Articles published before and in 2020, as well as those with follow-up under 5 years, also show a reduced risk, suggesting bariatric surgery may lower the likelihood of esophageal cancer development.
Journal Article by Zhu C, Liu W, Hu D and Peng L in Obes Surg
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.